Jack Cuzick
.jpg)
| Name | Jack Cuzick |
| Birth name | |
| Birth date | |
| Birth place | |
| Death date | |
| Death place | |
| Alma mater | |
| Occupation | |
| Years active | |
| Organization | |
| Known for | |
| Notable works | |
| Spouse(s) | |
| Website | |
Jack Cuzick is a prominent figure in the field of oncology. He is known for his significant contributions to cancer research, particularly in the areas of cancer prevention and epidemiology.
Early Life and Education[edit | edit source]
Details about Jack Cuzick's early life and education are not available.
Career[edit | edit source]
Cuzick has had a distinguished career in the field of oncology. He has conducted groundbreaking research in cancer prevention and epidemiology, focusing on identifying risk factors and developing strategies to reduce the incidence of cancer.
One of Cuzick's notable achievements is his work on the development of the Gail model for assessing breast cancer risk. This model has been widely used in clinical practice to estimate an individual's risk of developing breast cancer.
Cuzick has also been involved in research on the use of chemoprevention agents to reduce the risk of certain types of cancer. His studies have provided valuable insights into the effectiveness of these agents in preventing cancer development.
Awards and Recognition[edit | edit source]
Jack Cuzick has received numerous awards and honors for his contributions to the field of oncology. His work has been recognized for its impact on cancer prevention strategies and epidemiological research.
Publications[edit | edit source]
Cuzick has authored a significant number of research papers and articles in reputable scientific journals. His publications cover a wide range of topics related to cancer prevention, epidemiology, and risk assessment.
Legacy[edit | edit source]
Jack Cuzick's work has had a lasting impact on the field of oncology. His research has paved the way for advancements in cancer prevention and risk assessment, ultimately contributing to improved outcomes for patients.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
